Low rates of all-cause revision in displaced subcapital femoral neck fractures treated with hip hemiarthroplasty - a retrospective review of 4516 patients from a single institute

• Main Authors: Chi-Yung Yeung, Shang-Wen Tsai, Po-Kuei Wu, Cheng-Fong Chen, Ming-Chau Chang, Wei-Ming Chen
• Format: Article
• Language: English
• Published: BMC 2020-10-01
• Series: BMC Musculoskeletal Disorders
• Subjects: Femoral neck fractures; Austin Moore hemiarthroplasty; Bipolar hemiarthroplasty; Hemiarthroplasty failure; Conversion total hip replacement
• Online Access: http://link.springer.com/article/10.1186/s12891-020-03725-0

Abstract Background Femoral neck fracture (FNF) is among the commonest fractures affecting the geriatric population. Hemiarthroplasty (HA) is a standard treatment procedure and has been performed by hip surgeons for decades. Recently, primary total hip replacement has proved advantageous for the treatment of such fractures. The aim of this study is to retrospectively review all causes of failure of all patients who underwent HA in our institute and reevaluated whether HA remains a favourable choice of treatment for patients with displaced FNFs. Methods A total of 4516 patients underwent HA at our centre from 1998 to 2017. The HA implants included unipolar and bipolar prostheses. Patients diagnosed with displaced FNF, underwent primary HA initially, required second revision procedures, and followed up for a minimum of 36 months were included in this study. Data were collected and comprehensively analysed. Results In 4516 cases, 99 patients underwent second surgeries. The revision rate was 2.19%. Reasons for failure were acetabular wear (n = 30, 30.3%), femoral stem subsidence (n = 24, 24.2%), periprosthetic fracture (n = 22, 22.2%), infection (n = 16, 16.2%), and recurrent dislocation (n = 7, 7.1%). The mean follow-up period was 78.1 months. The interval between failed HA and revision surgery was 22.8 months. Conclusion HA has a low revision rate and remains a favourable choice of treatment for patients with displaced FNFs. Levels of evidence Level III, Retrospective Cohort Study, Therapeutic Study.